OS Therapies gears up for osteosarcoma drug approval
NEW YORK - OS Therapies, Inc. (NYSE-A: OSTX), a biotechnology firm focusing on cancer immunotherapies and targeted drug conjugates, with a current market capitalization of $37 million, has provided a ...
Booze or weed: What’s worse for your health?
Sorry, folks, but the short answer is that both can be bad.
Daily Express US on MSN34m
Alarming rise in lung cancer among non-smokers worldwide, study suggests
Lung cancer diagnoses are on the rise worldwide in those who have never smoked cigarettes, new research has shown.According ...
Merck Canada urges Canadians to take action for their lung health with new "Listen Close" campaign
Merck Canada has launched a new campaign called "Listen Close" to raise awareness for lung cancer and empower Canadians to ...